ElanA.01348.a
Glutamate--tRNA ligase
CENTER ID:
ElanA.01348.a
ORGANISM:
Elizabethkingia anophelis NUHP1
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
False
NIH RISK GROUP:
unclassified
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
unclassified
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
ElanA.01348.a.B1.GE41090
Full length(ElanA.01348.a)
info
1
503
ElanA.01348.a.B1.GE41090
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
ElanA.01348.a.B1.PW38250
Full length(ElanA.01348.a)
info
1
503
PW38250
Structures
6B1Z
DEPOSITED: 9/19/2017
DETERMINATION: XRay
CLONE: ElanA.01348.a.B1.GE41090
PROTEIN: ElanA.01348.a.B1.PW38250
Publications by SSGCID
Crystal structures of glutamyl-tRNA synthase from Elizabethkingia anopheles and E. meningosepticum
Dranow DM, Myler PJ, Subramanian S, Mayclin SJ, Asojo OA, Brooks L
Acta Crystallogr F Struct Biol Commun - 2022
volume 78, issue Pt 8, pages 306-312
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MEKVRVRFAP SPTGPLHLGG VRTALYDYLF AKHNGGDFIL RIEDTDTQRY VPGSEEYIME ALEWIGMVPD ESPKHGGPYA PYRQSERRDI YDRYTEQILK TDYAYLAFDT PEELDQIRAE FEARGDVFAY NYETRNRLRN SISLPEEEVK KLLEEKTPYV IRFKMPLDRI INLNDIIRGK FSVNTNTLDD KVLVKNDGMP TYHFANIIDD HEMKITHVIR GEEWLPSMAL HVLLYEAMGW DAPEFAHLSL ILKPEGKGKL SKRDGDKFGF PVFPLNFTDP ATGNTSAGYR EEGYLPEAFI NMVAMLGWSP ADNKEIVSMD EMIKEFDLNK VHKAGARFSA EKAKWFNQQY LQLMSNEAIL PEFKKVLAEN NVEVSDEKAL KIIGLMKERA TFVKDIYNDG KFFFHAPESF DEKASKKAWS PETAVLMQEL TEAISSLDFK AEIIKESIHH LAEAKGLGMG KVMMPLRLSL VGELKGPDVP DLMEMIGKEE TISRINKAIE TLK
NT Sequence
ATGGAAAAAG TACGGGTACG TTTTGCTCCC AGCCCAACCG GGCCTTTACA TTTGGGAGGT GTACGTACAG CATTATATGA CTATCTGTTT GCAAAACACA ATGGTGGTGA TTTTATCCTG AGAATCGAGG ATACCGATAC TCAGCGTTAT GTTCCGGGTT CCGAAGAGTA CATTATGGAA GCTCTGGAAT GGATTGGTAT GGTTCCGGAT GAAAGTCCAA AACATGGTGG TCCTTATGCT CCATATCGTC AGTCAGAACG TAGAGATATC TATGACAGAT ATACAGAACA AATCCTGAAA ACGGATTATG CTTACCTTGC TTTTGACACA CCTGAAGAAT TGGATCAGAT TCGTGCAGAA TTCGAAGCTA GAGGGGATGT TTTTGCCTAT AACTACGAAA CCCGTAACAG ACTAAGGAAT AGTATTTCTC TTCCTGAAGA AGAAGTAAAA AAACTTCTGG AAGAAAAAAC ACCATATGTA ATCCGTTTCA AAATGCCATT GGACAGAATC ATTAATCTTA ATGATATTAT CCGTGGGAAG TTTAGTGTAA ATACTAATAC CCTGGATGAT AAAGTTTTGG TAAAAAATGA CGGAATGCCA ACCTATCATT TCGCGAACAT TATTGATGAT CACGAGATGA AAATCACTCA TGTTATCCGT GGTGAGGAAT GGCTGCCATC TATGGCACTT CATGTATTAT TATATGAAGC AATGGGTTGG GATGCTCCGG AATTCGCCCA CCTTTCACTT ATCCTGAAAC CTGAAGGAAA AGGTAAACTA AGCAAAAGAG ATGGTGATAA ATTCGGTTTC CCTGTTTTCC CGCTTAACTT TACTGATCCT GCTACAGGCA ATACCTCTGC CGGTTATCGT GAAGAAGGTT ATTTACCAGA AGCTTTCATC AATATGGTTG CCATGTTGGG ATGGTCTCCT GCTGACAATA AAGAAATTGT GAGTATGGAT GAAATGATTA AAGAATTCGA TCTTAATAAA GTTCATAAAG CAGGAGCAAG ATTCAGTGCA GAAAAAGCAA AATGGTTCAA TCAGCAATAT TTGCAACTGA TGTCTAATGA AGCTATACTT CCTGAATTTA AAAAAGTACT GGCAGAAAAC AATGTTGAAG TTTCTGATGA GAAAGCTTTA AAAATCATTG GTCTGATGAA AGAAAGAGCA ACCTTTGTTA AAGACATCTA TAATGACGGT AAATTCTTTT TCCATGCACC GGAATCTTTT GATGAAAAGG CTTCGAAAAA AGCATGGTCT CCGGAAACAG CTGTATTAAT GCAAGAATTA ACCGAGGCTA TTTCATCTCT AGATTTTAAG GCTGAAATTA TTAAAGAAAG TATCCACCAT CTGGCAGAAG CCAAAGGATT GGGTATGGGA AAAGTAATGA TGCCCCTGAG ACTTTCTTTA GTTGGAGAAC TTAAAGGACC AGACGTACCG GATCTTATGG AAATGATCGG AAAAGAAGAG ACTATTTCCA GAATTAATAA AGCAATTGAA ACTTTAAAA
Details for ElanA.01348.a.B1.GE41090
HARVESTED ON:
2/8/2017
SEQUENCED ON:
2/13/2017
EXPECTED MW:
59kDa
OBSERVED MW:
58kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Too many to count (100+)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
100
PERCENT COVERAGE:
98
Details for ElanA.01348.a.B1.PW38250
PURIFICATION DATe:
4/10/2017
CONCENTRATION:
36.5mg/ml
OBSERVED MW:
61kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
13
VIAL VOLUME:
200µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
98